Retatrutide (RETA) is a synthetic peptide investigated for its activity as a triple receptor agonist targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptors.
Its molecular structure is designed to interact with three distinct receptor systems involved in metabolic signalling. Research into retatrutide focuses on receptor activation, intracellular signalling cascades and the molecular mechanisms governing energy metabolism and glucose regulation.





